Interleukin-5 Receptor alpha-directed Cytolytic Antibody drugs
1 medication in the FDA established pharmacologic class “Interleukin-5 Receptor alpha-directed Cytolytic Antibody”.
| Drug | Type | NDC products |
|---|---|---|
| Fasenra Benralizumab | Rx | 3 |
1 medication in the FDA established pharmacologic class “Interleukin-5 Receptor alpha-directed Cytolytic Antibody”.
| Drug | Type | NDC products |
|---|---|---|
| Fasenra Benralizumab | Rx | 3 |